EGFR Gene Signature May Predict Prognosis and Guide Treatment in Lung Cancer

EGFR Gene Signature May Predict Prognosis and Guide Treatment in Lung Cancer

The BATTLE I trial is part of a set of studies that are examining the genetic profiles of individual tumors and then assigning therapies that offer the best benefits on the basis of the tumor's unique characteristics. "The EGFR-mutation signature will be evaluated as a predictor of response in the BATTLE I trial," said Dr. Saintigny, adding that they will be presenting those results later this year at the annual meeting of the American Society of Clinical Oncology.

POST COMMENT

Esophageal Cancer Chemotherapy Esophageal Cancer Metastasis, Best Natural Remedies Stage Iv Esophageal Cancer, Natural Cure For Cancer Two Most Common Types Of Esophageal Cancer, Natural Remedies Peel apples are anti. Anti-oxidant protect cancer Cabbage anti Cancer Real Cancer Solutions Which Genuinely Execute Life Expectancy Lung Cancer Patients Have Treatment Of Testicular Cancer Tomotherapy Esophageal Cancer About esophagus cancer surgery methods How To Deal With Cancer Forecast Barrett esophagus cancer risk factors